Investor Relations

Stock Quote

About SWK Holdings

We are a specialized finance company with a specific focus on opportunities in the global healthcare sector. We provide innovative capital solutions to a broad range of life science companies, institutions and inventors.

We provide capital to our business partners through our own balance sheet as well as through our investment advisory clients, which include family offices and institutional investors. Our broad capital base positions us to be the partner of choice for life science entities looking for flexible, nontraditional sources of capital.

Our management team has extensive experience specifically in healthcare-related principal investing and structured finance, resulting in a deep understanding of business opportunities in the life science sector.

For our investors, we expect to provide superior risk-adjusted returns on capital by investing in marketed ethical product cash flow streams.

Latest News
Sep 12, 2022

Physicochemical properties of peptides can provide key insights to potential success of oral delivery BOONTON, N.J., Sept. 12, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company...

Sep 07, 2022

SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that...

Sep 01, 2022

Jody Staggs appointed as President and Interim CEO CEO Winston Black will assist in an interim consulting role after successfully establishing SWK Holdings as a leading life science focused...

View All Releases

Latest Presentation

Shareholder Presentation – September 2022
September 12, 2022

Upcoming & Recent Events
Contact Us

Jason Rando
Tiberend Strategic Advisors, Inc.
(917) 930-6346


To see news related to SWK Holdings' Portfolio, click here.

Latest Quarterly Results